Abstract:To analyze the treatment effect of the curcumin nanoparticle drug delivery system to the Alzheimer’s disease (AD), the NP-Cur, NP-S1-Cur, and NP-S1-Cur-CRT nanoparticles were prepared by combining the various internal water phases based on the emulsification volatilization method for the cytotoxicity test and applied to treatment of β-amyloid precursor protein/pistilloid-stamen 1 (APP/PS1) double transgenic (DT) mice in three groups, which were group W1 (treated with NP-Cur), W2 (treated with NP-S1-Cur), W3 (treated with NP-S1-Cur-CRT), W4 (treated with curcumin drugs), and W0 (normal control), respectively. Immunohistochemistry was adopted to detect the senile plaques (amyloid precursor antibody, 6E10), microglia (IBA-1), and astrocytes (glial fibrillary acidic protein, GFAP). The spatial memory ability (SMA) of mice was evaluated by the Y maze experiment, and the learning memory ability (LMA) of mice was evaluated by the new thing cognition experiment. The results showed that in the human neuroblastoma cell (SH-SY5Y), mouse brain microvascular endothelial cell line (bEnd.3), and mouse microglia cell line (BV2), the cell activity (CA) caused by NP-Cur, NP-S1-Cur, and NP-S1-Cur-CRT nanoparticles all decreased with the increase of concentration value of curcumin, but all were higher than 80%; it was found based on the Y maze experiment that the stay time (ST) and the number of entries (NE) in the group W4 were higher than those in group W1, W2, and W3 (P < 0.05); the frequency of exploring new things in the group W0 was higher than the frequency in W1, W2, and W3 (P < 0.05). There was no remarkable difference in the exploration frequency of new things in group W4 and W0 (P > 0.05); the positive units (PU values) of cytoplasm and nucleus (C&N) 6E10 protein in W4 were lower than the values in W1, W2, and W3 (P > 0.05); the PU value of C&N IBA-1 protein of W4 was lower than the value in W1, W2, and W3 (P < 0.05); the PU value of C&N GFAP protein expression in group W4 was lower obviously than the value in W1, W2, and W3 (P < 0.05). In short, poly lactic-co-glycolic acid (PLGA) nanoparticles loaded with curcumin had good biosafety and compatibility. It can effectively improve the LMA of APP/PS1 mice, reduce the area of senile plaques, and have better neuroprotective function. Among them, the NP-S1-Cur-CRT nanoparticles had the best improvement effect.

Detection and monitoring of the neuroprotective behavior of curcumin micelles based on an AIEgen probe

Curcumin Mitigates Aβ33-42 Fibril-Induced Neuronal Injury in the Hippocampus

Study on the Application of a Novel Nano-Curcumin Drug for Alzheimer's Disease

Potential therapeutic effects of curcumin: relationship to microtubule-associated proteins 2 in Aβ1-42 insult.

Curcumin alleviates Alzheimer's disease by inhibiting inflammatory response, oxidative stress and activating the AMPK pathway

Inhibitory Effect of Curcumin on the Al(III)-induced Aβ42 Aggregation and Neurotoxicity in Vitro

The synergistic effect of curcumin and mitoquinol mesylate on cognitive impairment and the neuropathology of Alzheimer's disease

Non-invasive optical imaging of retinal Aβ plaques using curcumin loaded polymeric micelles in APP swe /PS1 ΔE9 transgenic mice for the diagnosis of Alzheimer's disease.

Synthesis and evaluation of curcumin-based near-infrared fluorescent probes for detection of amyloid β peptide in Alzheimer mouse models

Curcumin Complex Analogues as Near-Infrared Fluorescent Probes for Monitoring all A beta Species in the Early Alzheimer's Disease Model

A Novel Nanosystem Realizing Curcumin Delivery Based on Fe3O4@Carbon Dots Nanocomposite for Alzheimer’s Disease Therapy

Omnidirectional improvement of mitochondrial health in Alzheimer's disease by multi-targeting engineered activated neutrophil exosomes

The Potential Protective Effect of Curcumin on Amyloid- β -42 Induced Cytotoxicity in HT-22 Cells.

Non-invasive optical imaging of retinal A plaques using curcumin loaded polymeric micelles in APP<sub>swe</sub>/PS1<sub>E9</sub>transgenic mice for the diagnosis of Alzheimer's disease

The impacts of curcumin on learning memory function in Alzheimer’s disease under the poly lactic-co-glycolic acid nanoparticle drug carrier

A Curcumin Analog Reduces Levels of the Alzheimer’s Disease-Associated Amyloid-β Protein by Modulating AβPP Processing and Autophagy

Functional bioprobe for responsive imaging and inhibition of amyloid-β oligomer based on curcuminoid scaffold

Curcumin Attenuated Neurotoxicity in Sporadic Animal Model of Alzheimer’s Disease

Design, Synthesis, and Biological Evaluation of Curcumin Analogues As Multifunctional Agents for the Treatment of Alzheimer’s Disease

Highly Sensitive Curcumin-conjugated Nanotheranostic Platform for Detecting Amyloid-Beta Plaques by Magnetic Resonance Imaging and Reversing Cognitive Deficits of Alzheimer's Disease Via NLRP3-inhibition.

Curcumin Scaffold As a Multifunctional Tool for Alzheimer's Disease Research.